Dana Borden Lacy

Prof. Dr. Dana Borden Lacy

Vanderbilt University School of Medicine, Department of Pathology, Microbiology and Immunology, A-4116A Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2016 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
WSWiep Klaas Smits
Wiep Klaas Smits
DLDena Lyras
Dena Lyras
DLDana Borden Lacy
Dana Borden Lacy
MWMark H. Wilcox
Mark H. Wilcox
EKEd J. Kuijper
Ed J. Kuijper

1 October 1998 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
DLDana Borden Lacy
Dana Borden Lacy
WTWilliam Tepp
William Tepp
ACAlona C. Cohen
Alona C. Cohen
BDBibhuti R. DasGupta
Bibhuti R. DasGupta
RSRaymond Charles Stevens
Raymond Charles Stevens

18 October 2017 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
RCRamyavardhanee Chandrasekaran
Ramyavardhanee Chandrasekaran
DLDana Borden Lacy
Dana Borden Lacy
Clostridium difficile is a bacterial pathogen that is the leading cause of nosocomial antibiotic-associated diarrhea and pseudomembranous colitis worldwide. The incidence, severity, mortality and healthcare costs associated with C. difficile infection (CDI) are rising, making C. difficile a major threat to public health. Traditional treatments for CDI involve use of antibiotics such as metronidazole and vancomycin, but disease recurrence occurs in about 30% of patients, highlighting the need for new therapies. The pathogenesis of C. difficile is primarily mediated by the actions of two large clostridial glucosylating toxins, toxin A (TcdA) and toxin B (TcdB). Some strains produce a third toxin, the binary toxin C. difficile transferase, which can also contribute to C. difficile virulence and disease. These toxins act on the colonic epithelium and immune cells and induce a complex cascade of cellular events that result in fluid secretion, inflammation and tissue damage, which are the hallmark features of the disease. In this review, we summarize our current understanding of the structure and mechanism of action of the C. difficile toxins and their role in disease.

8 November 2001 in Nature
Verified
Journal Article
Closed access
PDF file
APAndrew D. Pannifer
Andrew D. Pannifer
TWThiang Yian Wong
Thiang Yian Wong
RSRobert Schwarzenbacher
Robert Schwarzenbacher
MRMartin Renatus
Martin Renatus
CPCarlo Petosa
Carlo Petosa
RLRobert C. Liddington
Robert C. Liddington

29 July 2005 in Science
Verified
Journal Article
Closed access
PDF file
BKBryan A. Krantz
Bryan A. Krantz
RMRoman A. Melnyk
Roman A. Melnyk
SZSen Zhang
Sen Zhang
SJStephen J. Juris
Stephen J. Juris
DLDana Borden Lacy
Dana Borden Lacy
RCR. John Collier
R. John Collier
The protective antigen component of anthrax toxin forms a homoheptameric pore in the endosomal membrane, creating a narrow passageway for the enzymatic components of the toxin to enter the cytosol. We found that, during conversion of the heptameric precursor to the pore, the seven phenylalanine-427 residues converged within the lumen, generating a radially symmetric heptad of solvent-exposed aromatic rings. This “φ-clamp” structure was required for protein translocation and comprised the major conductance-blocking site for hydrophobic drugs and model cations. We conclude that the φ clamp serves a chaperone-like function, interacting with hydrophobic sequences presented by the protein substrate as it unfolds during translocation.

1 September 1999 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DLDana Borden Lacy
Dana Borden Lacy
RSRaymond Charles Stevens
Raymond Charles Stevens